Mitochondria: An intriguing target for killing tumour-initiating cells-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Mitochondria: An intriguing target for killing tumour-initiating cells

Published:2016-01 Issue: Volume:26 Page:86-93
ISSN:1567-7249
Container-title:Mitochondrion
language:en
Short-container-title:Mitochondrion

Author:

Yan Bing,Dong Lanfeng,Neuzil Jiri

Funder

Australian Research Council

Czech Science Foundation

BIOCEV European Regional Development Fund

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Molecular Medicine

Reference117 articles.

1. Prospective identification of tumorigenic breast cancer cells;Al-Hajj;Proc. Natl. Acad. Sci. U. S. A.,2003

2. NV-128, a novel isoflavone derivative, induces caspase-independent cell death through the Akt/mammalian target of rapamycin pathway;Alvero;Cancer,2009

3. Targeting the mitochondria activates two independent cell death pathways in ovarian cancer stem cells;Alvero;Mol. Cancer Ther.,2011

4. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells;Baba;Oncogene,2009

5. Tumor initiating cells;Bansal;Curr. Pharm. Biotechnol.,2009

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria-Targeted Ergosterol Peroxide Derivatives: Synthesis, Anticancer Properties and Their Preliminary Mechanism of Inhibiting MCF-7 Cell Proliferation;Journal of the Brazilian Chemical Society;2023

2. Is the Mitochondrial Membrane Potential (∆Ψ) Correctly Assessed? Intracellular and Intramitochondrial Modifications of the ∆Ψ Probe, Rhodamine 123;International Journal of Molecular Sciences;2022-01-01

3. The Efficacy of Vitamin K, A Member Of Naphthoquinones in the Treatment of Cancer: A Systematic Review and Meta-Analysis;Current Cancer Drug Targets;2021-09-01

4. Dual‐Targeting Polymeric Nanocarriers to Deliver ROS‐Responsive Prodrugs and Combat Multidrug Resistance of Cancer Cells;Macromolecular Bioscience;2021-06-18

5. An Angiopep2-PAPTP Construct Overcomes the Blood-Brain Barrier. New Perspectives against Brain Tumors;Pharmaceuticals;2021-02-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3